SCM
ARRY

Stevens Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Stevens Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-14,796
Closed -$225K – 1028
2018
Q3 		$225K Sell
14,796
-1,869
-11% -$28.6K 0.01% 633
2018
Q2 		$280K Buy
+16,665
New +$265K 0.01% 641
2016
Q1 		– Sell
-40,164
Closed -$169K – 1202
2015
Q4 		$169K Sell
40,164
-97,271
-71% -$444K 0.01% 822
2015
Q3 		$627K Buy
137,435
+18,901
+16% +$112K 0.03% 468
2015
Q2 		$855K Buy
118,534
+64,542
+120% +$476K 0.03% 461
2015
Q1 		$398K Buy
53,992
+21,055
+64% +$150K 0.01% 642
2014
Q4 		$156K Buy
+32,937
New +$130K 0.01% 891
2013
Q3 		– Sell
-12,867
Closed -$58K – 1278
2013
Q2 		$58K Buy
+12,867
New +$69.2K ﹤0.01% 881

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return